Epidemiological studies show that high levels of IGF1 and low levels of IGFBP3 are associated with an increased risk for several common cancers, including cancer of the prostate, breast, lung, and colorectum [6]–[8]. This evidence concerns the gene IGFBP3 and prostate carcinoma.